Abstract:Background and PurposeImmunosuppressive drugs have shown great promise in treating autoimmune diseases in recent years. A series of novel oxazole derivatives were screened for their immunosuppressive activity. PO‐322 [1H‐indole‐2,3‐dione 3‐(1,3‐benzoxazol‐2‐ylhydrazone)] was identified as the most effective of these compounds. Here, we have investigated the mechanism(s) underlying the inhibition of T‐cell proliferation in vitro by PO‐322, as well as its effects on the delayed‐type hypersensitivity (DTH) response and imiquimod‐induced dermatitis in vivo.Experimental ApproachT‐cell proliferation and apoptosis were analysed with flow cytometry. Cell viability was assessed with a CCK‐8 assay. Protein kinase activity was assessed by SelectScreen Kinase Profiling Services. The phosphorylation of signal‐regulated molecules was measured by Western blot. Cytokine levels were determined by elisa. The effect of PO‐322 on DTH and imiquimod‐induced dermatitis was evaluated in BALB/c mice.Key ResultsPO‐322 inhibited human T‐cell proliferation with anti‐CD3/anti‐CD28 mAbs or alloantigen without significant cytotoxicity. Importantly, PO‐322 was a selective inhibitor of the serum‐ and glucocorticoid‐regulated kinase 1 (SGK1) and decreased NDRG1 phosphorylation but not p70S6K, STAT5, Akt, or ERK1/2 phosphorylation. Furthermore, PO‐322 inhibited IFN‐γ, IL‐6, and IL‐17 expression but not IL‐10 expression. Finally, treatment with PO‐322 was safe and effective for ameliorating the DTH response and imiquimod‐induced dermatitis in mice.Conclusions and ImplicationsPO‐322 exerted immunosuppressive activity in vitro and in vivo by selectively inhibiting SGK1 activity. PO‐322 represents a potential lead compound for the design and development of new drugs for the treatment of autoimmune diseases.

(E)-1,3-diphenyl-1h-pyrazole Derivatives Containing O-benzyl Oxime Moiety As Potential Immunosuppressive Agents: Design, Synthesis, Molecular Docking and Biological Evaluation.

Synthesis, biological evaluation and molecular docking studies of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents

Synthesis, molecular docking and biological evaluation of 1,3,4-oxadiazole derivatives as potential immunosuppressive agents.

Design, synthesis, biological evaluation and molecular modeling of novel 1,3,4-oxadiazole derivatives based on Vanillic acid as potential immunosuppressive agents.

Synthesis, biological evaluation and molecular modeling studies of Schiff bases derived from 4-methylsalicylic acid as potential immunosuppressive agents

Oxadiazole Derivatives Containing 1,4-Benzodioxan As Potential Immunosuppressive Agents Against RAW264.7 Cells.

Design, Synthesis, and Immunosuppressive Activity of New Deoxybenzoin Derivatives

Synthesis and evaluation of a novel series of quinoline derivatives with immunosuppressive activity.

Design, Synthesis, and Biological Evaluation of Chalcone Oxime Derivatives As Potential Immunosuppressive Agents

The design, synthesis and in vitro immunosuppressive evaluation of novel isobenzofuran derivatives.

Synthesis And Immunomodulating Activity Of New Analogues Of Fingolimod

Design and Synthesis of Marine Phidianidine Derivatives As Potential Immunosuppressive Agents

Synthesis of N‐Substituted Iminosugar Derivatives and Evaluation of Their Immunosuppressive Activities

PO‐322 Exerts Potent Immunosuppressive Effects in Vitro and in Vivo by Selectively Inhibiting SGK1 Activity

Synthesis and anti-inflammatory effects of novel emodin derivatives bearing azole moieties

Synthesis and Biological Activities of Novel Benzoxazolinone/Benzothiazolone Derivatives Containing Oxadiazole Moiety

Pharmacological Evaluation of 9,10-Dihydrochromeno[8,7- E ][1,3]Oxazin-2(8 H )-One Derivatives As Potent Anti-Inflammatory Agent

Synthesis, Crystal Structure and Immunosuppressive Activity of Acylamide Derivatives Containing 1,4-Benzodioxan.

Synthesis and biological evaluation of novel 5-benzylidenethiazolidine-2,4-dione derivatives for the treatment of inflammatory diseases.

Synthesis and Immunosuppressive Activity of New Amino Alcohols Derivatives(Ii)

Synthesis of novel cinnamanilides as potential immunosuppressive agents.